期刊文献+
共找到62篇文章
< 1 2 4 >
每页显示 20 50 100
Screening of Common Traditional Chinese Drugs for Reversing Multidrug Resistance of KBV200 In Vitro 被引量:1
1
作者 张庆林 赵精华 +5 位作者 曹菊荣 宋京 毕建进 王小娜 龚萍 吴祖泽 《Journal of Chinese Pharmaceutical Sciences》 CAS 2002年第3期64-67,共4页
The ethanolic extracts of 100 common traditional Chinese drugs, which are widely used in many prescriptions in treatment of cancer in China, were screened for MDR of KBV200 cell line in vitro with MTT method. The ... The ethanolic extracts of 100 common traditional Chinese drugs, which are widely used in many prescriptions in treatment of cancer in China, were screened for MDR of KBV200 cell line in vitro with MTT method. The result showed 9 extracts having MDR reversal activity. They were the extracts of Fructus Lagenariae Sicerariae, Radix Glycyrrhizae, Poria, Herba Andrographitis, Radix Sophorae Tonkinensis, Caulis Mahoniae, Folium Artemisiae Argyi, Rhizoma Curcumae, Fructus Cnidii. Other 5 extracts showed cytotoxic on KBV200 cell line. $$$$ 展开更多
关键词 Traditional Chinese drugs Reversing MDR screening in vitro
下载PDF
Screening of Common Traditional Chinese Drugs for Reversing Multidrug Resistance of KBV200 In Vitro 被引量:4
2
作者 张庆林 赵精华 +5 位作者 曹菊荣 宋京 毕建进 王小娜 龚萍 吴祖泽 《Journal of Chinese Pharmaceutical Sciences》 CAS 2002年第3期64-67,共页
The ethanolic extracts of 100 common traditional Chinese drugs, which are widely used in many prescriptions in treatment of cancer in China, were screened for MDR of KBV200 cell line in vitro with MTT method. The ... The ethanolic extracts of 100 common traditional Chinese drugs, which are widely used in many prescriptions in treatment of cancer in China, were screened for MDR of KBV200 cell line in vitro with MTT method. The result showed 9 extracts having MDR reversal activity. They were the extracts of Fructus Lagenariae Sicerariae, Radix Glycyrrhizae, Poria, Herba Andrographitis, Radix Sophorae Tonkinensis, Caulis Mahoniae, Folium Artemisiae Argyi, Rhizoma Curcumae, Fructus Cnidii. Other 5 extracts showed cytotoxic on KBV200 cell line. $$$$ 展开更多
关键词 Traditional Chinese drugs Reversing MDR screening in vitro
全文增补中
Anticancer drug screening of natural products:In vitro cytotoxicity assays,techniques,and challenges 被引量:1
3
作者 Agustina Setiawati Damiana Sapta Candrasari +3 位作者 F.D.Erika Setyajati Vincentia Krisnina Prasetyo Dewi Setyaningsih Yustina Sri Hartini 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2022年第7期279-289,共11页
Natural products include several diverse compounds that have been found to be effective against cancer.Discovering anticancer compounds in nature is a multistep and complex process that requires pre-clinical and clini... Natural products include several diverse compounds that have been found to be effective against cancer.Discovering anticancer compounds in nature is a multistep and complex process that requires pre-clinical and clinical studies.Only a few of the available natural products are used to treat cancer since most of them have very high complexity and low bioavailability.Therefore,the process of anticancer drug discovery requires a straightforward and effective method to assess anticancer activity using in vitro assays.This review summarizes various cell-based assays and techniques used to measure cell viability,migration,and apoptosis,focusing in particular on the principles,mechanisms,advantages,and disadvantages of each assay to provide a preliminary platform for cancer drug discovery. 展开更多
关键词 Drug discovery CANCER Natural products screening in vitro assay cytotoxicITY MIGRATION APOPTOSIS
下载PDF
Drug Screening Experiment in vitro of Fox Eperythrozoon
4
作者 高光平 高桂生 +1 位作者 史秋梅 张艳英 《Agricultural Science & Technology》 CAS 2013年第11期1639-1641,共3页
[Objective] The research aimed to make the drug screening experiment in vitro of eperythrozoon of fox. [Method] RPMI-1640 was used as the basic culture medium and 30% calf serum was added. Using Berenil, oxytetracycli... [Objective] The research aimed to make the drug screening experiment in vitro of eperythrozoon of fox. [Method] RPMI-1640 was used as the basic culture medium and 30% calf serum was added. Using Berenil, oxytetracycline, al icin, doxy-cycline,imidocarb,florfenicol,Fuhongjuesha,primaquine phosphate and other drug powder,the drug screening experiment in vitro of fox eperythrozoon was made under the conditions of 37.3 ℃, 5% CO2. [Result] The effects of Fuhongjuesha was the best,and that of primaquine phosphate and Berenil was the next. And imidocarb,al-licin and florfenicol were effective. [Conclusion] The research provided scientific and theoretical basis for the clinical treatment of eperythrozoonosis. 展开更多
关键词 EPERYTHROZOON Fox in vitro Drug screening
下载PDF
Bioprinting of novel 3D tumor array chip for drug screening 被引量:10
5
作者 Mingjun Xie Qing Gao +2 位作者 Jianzhong Fu Zichen Chen Yong He 《Bio-Design and Manufacturing》 SCIE CSCD 2020年第3期175-188,共14页
Biomedical field has been seeking a feasible standard drug screening system consisting of 3D tumor model array for drug researching due to providing sufficient samples and simulating actual in vivo tumor growth situat... Biomedical field has been seeking a feasible standard drug screening system consisting of 3D tumor model array for drug researching due to providing sufficient samples and simulating actual in vivo tumor growth situation,which is still a challenge to rapidly and uniformly establish though.Here,we propose a novel drug screening system,namely 3D tumor array chip with“layer cake”structure,for drug screening.Accurate gelatin methacryloyl hydrogel droplets(~0.1μL)containing tumor cells can be automatically deposited on demand with electrohydrodynamic 3D printing.Transparent conductive membrane is introduced as a chip basement for preventing charges accumulation during fabricating and convenient observing during screening.Culturing chambers formed by stainless steel and silicon interlayer is convenient to be assembled and recycled.As this chip is compatible with the existing 96-well culturing plate,the drug screening protocols could keep the same as convention.Important properties of this chip,namely printing stability,customizability,accuracy,microenvironment,tumor functionalization,are detailly examined.As a demonstration,it is applied for screening of epirubicin and paclitaxel with breast tumor cells to confirm the compatibility of the proposed screening system with the traditional screening methods.We believe this chip will potentially play a significant role in drug evaluation in the future. 展开更多
关键词 3D tumor array chip(3D-TAC) Gelatin methacryloyl(GelMA) Drug screening in vitro model BIOPRinTinG
下载PDF
Fabrication of paper-based devices for in vitro tissue modeling 被引量:3
6
作者 Hongbin Li Feng Cheng +3 位作者 Juan A.Robledo-Lara Junlong Liao Zixuan Wang Yu Shrike Zhang 《Bio-Design and Manufacturing》 SCIE CSCD 2020年第3期252-265,共14页
Paper devices have recently attracted considerable attention as a class of cost-effective cell culture substrates for various biomedical applications.The paper biomaterial can be used to partially mimic the in vivo ce... Paper devices have recently attracted considerable attention as a class of cost-effective cell culture substrates for various biomedical applications.The paper biomaterial can be used to partially mimic the in vivo cell microenvironments mainly due to its natural three-dimensional characteristic.The paper-based devices provide precise control over their structures as well as cell distributions,allowing recapitulation of certain interactions between the cells and the extracellular matrix.These features have shown great potential for the development of normal and diseased human tissue models.In this review,we discuss the fabrication of paper-based devices for in vitro tissue modeling,as well as the applications of these devices toward drug screening and personalized medicine.It is believed that paper as a biomaterial will play an essential role in the field of tissue model engineering due to its unique performances,such as good biocompatibility,eco-friendliness,cost-effectiveness,and amenability to various biodesign and manufacturing needs. 展开更多
关键词 Paper-based devices in vitro Tissue modeling Disease modeling Drug screening Personalized medicine
下载PDF
Xenobiotic effects in cancer related pathways-high throughput screening and proof of concept in animal models
7
作者 Ursula E. Schumacher 《中国比较医学杂志》 CAS 2013年第1期69-80,共12页
Xenobiotic drugs and chemicals directly interact with DNA,proteins,or other biomolecules in cells. These direct interactions with molecular targets may trigger a series of downstream effects on metabolic-biochemical a... Xenobiotic drugs and chemicals directly interact with DNA,proteins,or other biomolecules in cells. These direct interactions with molecular targets may trigger a series of downstream effects on metabolic-biochemical and regulatory-signaling networks that can invoke cellular consequences leading to adaptive homeostatic or adverse pathological responses. Regulators for drug and chemicals safety have therefore since long required the testing of toxicity in animal models before drugs and pesticides can enter the market. The US National Research Council of the National Academy of Sciences,in its report,Toxicity Testing in the 21st Century: a Vision and a Strategy [1] ,proposed that toxicity testing should become less reliant on apical endpoints from whole animal tests and eventually rely instead on quantitative,doseresponse models based on information from in vitro assays and in vivo biomarkers,which can be used to screen large numbers of chemicals. The present paper reports about a combination of HTS in vitro assays that can be used to study the potential tumorigenic effect of xenobiotics ( drug targets,environmental chemicals) via a set of"sentinel"genes [2] that are functionally interrelated based on evidence weighted functional linkage network ( FLN ) log-likelihood scores ( Linghu et al [3] ) . 展开更多
关键词 基础医学 呼吸生理 呼吸运动 人体生理学
下载PDF
Preparation and Characterization of Paclitaxel/Chitosan Nanosuspensions for Drug Delivery System and Cytotoxicity Evaluation In Vitro 被引量:3
8
作者 Yongjia Liu Fengren Wu +3 位作者 Yongle Ding Bangshang Zhu Yue Su Xinyuan Zhu 《Advanced Fiber Materials》 CAS 2019年第2期152-162,共11页
In this study,we prepared paclitaxel/chitosan(PTX/CS)nanosuspensions(NSs)with different mass ratios of PTX and CS(1.5:2,2:2,and 2.5:2),for controlled drug delivery purposes.For attachment and dispersion in water mediu... In this study,we prepared paclitaxel/chitosan(PTX/CS)nanosuspensions(NSs)with different mass ratios of PTX and CS(1.5:2,2:2,and 2.5:2),for controlled drug delivery purposes.For attachment and dispersion in water medium,a simple ultrasonic disruption technique was employed.The water-dispersed PTX/CS NSs exhibited a rod-shape morphology with an average diameter of 170-210 nm and average length of about 1-10μm.Transmission electron microscopy,differential scan-ning calorimetry and X-ray diffraction indicated that the obtained PTX/CS NSs contain a nanocrystalline PTX phase.It was also inferred that presence of CS can promotes the crystalline nature of PTX up to 80%.In addition,efficiency of PTX loading reached over 85%in freeze-dried PTX/CS NSs,showing a slow rate of drug release in vitro for 8 days.The MTT and LDH assessments revealed that PTX/CS NSs significantly inhibit the growth of tumor cells(HeLa),while it is slightly toxic for the normal cells(NIH/3T3).Therefore,PTX/CS NSs is suggested as a potential nanodrug delivery system for cancer therapy. 展开更多
关键词 PACLITAXEL CHITOSAN NANOSUSPENSIONS Drug release cytotoxicity in vitro
原文传递
星点设计-效应面法优化万古霉素-聚富马酸丙二醇酯/聚乳酸-羟基乙酸共聚物微球的制备工艺
9
作者 王江华 尹东锋 +6 位作者 滕勇 乌日开西·艾依提 王晓锋 马热艳木·艾尼 蒋厚峰 帕提古丽·艾合麦提 王晶 《中国组织工程研究》 CAS 北大核心 2023年第16期2510-2517,共8页
背景:万古霉素为骨髓炎治疗首选抗生素之一,局部给药不仅能发挥其抗菌作用,而且还能大幅减少全身不良反应。目的:优选万古霉素-聚富马酸丙二醇酯/聚乳酸-羟基乙酸共聚物微球的制备工艺,并考察其体外释放行为及细胞毒性。方法:采用复乳... 背景:万古霉素为骨髓炎治疗首选抗生素之一,局部给药不仅能发挥其抗菌作用,而且还能大幅减少全身不良反应。目的:优选万古霉素-聚富马酸丙二醇酯/聚乳酸-羟基乙酸共聚物微球的制备工艺,并考察其体外释放行为及细胞毒性。方法:采用复乳溶剂挥发法(W1/O/W2)制备万古霉素-聚富马酸丙二醇酯/聚乳酸-羟基乙酸共聚物微球,以微球的包封率和载药量为评价指标,应用星点设计-效应面法考察聚富马酸丙二醇酯和聚乳酸-羟基乙酸共聚物质量比、聚富马酸丙二醇酯和聚乳酸-羟基乙酸共聚物与万古霉素的质量比、二氯甲烷浓度对制备工艺的影响,对结果进行多元线性回归和二项式拟合,效应面法优选最佳工艺条件,测量微球的粒径、ζ电位、体外释放行为及细胞毒性。结果与结论:(1)成功制备了微球,优选聚合物微球的最佳制备工艺为:聚富马酸丙二醇酯与聚乳酸-羟基乙酸共聚物的质量比=2.41、聚富马酸丙二醇酯/聚乳酸-羟基乙酸共聚物与药物质量比=3.56、CH2Cl2浓度为129.73 g/L,实测平均包封率为83.38%,与预测值相比偏差为0.63%;实测平均载药量为18.19%,与预测值相比偏差为0.55%;(2)最佳工艺制得微球的平均粒径为103.902μm,ζ电位为-21.5 mV;微球体外3 d后累计释药量为(22.90±0.55)%,28 d后累计释放量达(43.57±1.02)%,28 d后微球释药明显增快,42 d时累计释放量为(97.89±1.39)%;微球细胞毒性分级为1级;(3)星点设计-效应面法优化微球制备工艺预测性良好,所优化的制备工艺重现性好、简单易行,所制备的微球具有较好的体外缓释特性和生物相容性。 展开更多
关键词 万古霉素 聚乳酸-羟基乙酸共聚物 聚富马酸丙二醇酯 微球 复乳溶剂挥发法 星点设计-效应面法 体外释药 细胞毒性
下载PDF
Preliminary Screening of Non-platinum Complexes of Schiff Bases as Antitumour Agents Using Fluorimetry
10
作者 李志良 陈建华 +2 位作者 章开诚 李梦龙 俞汝勤 《Science China Chemistry》 SCIE EI CAS 1993年第2期214-224,共11页
Based on the consistency of the in vivo and in vitro interactions of drugs with DNA, a fluorimetric method has been developed as a new in vitro method for preliminary screening of antitumour agents. This method was te... Based on the consistency of the in vivo and in vitro interactions of drugs with DNA, a fluorimetric method has been developed as a new in vitro method for preliminary screening of antitumour agents. This method was tested using Schiff bases synthesized from salicylaldehyde with 1-alanine, 1-asparagine and 1-histidine, and complexes of these Schiff bases with Cu(Ⅱ), Zn(Ⅱ), Ni(Ⅱ) and Sn(Ⅳ) as potential antitumour agents.The study of the interaction of the complexes with DNA by a fluorescence probe ethidium bromide (EthBr)-DNA system indicated the parallelism between the binding constants and antineoplastic ratios. The relationship between structure and antitumonr activity was investigated. 展开更多
关键词 fluoreseenee probe in vitro screening of ANTITUMOUR drugs non-platinum complex of SCHIFF base.
原文传递
细胞培养筛选抗球虫剂程序的研究 被引量:8
11
作者 谢明权 谢宏料 +3 位作者 吴惠贤 彭新宇 魏文康 温列娜 《畜牧兽医学报》 CAS CSCD 北大核心 1997年第3期278-283,共6页
本文作者在Eimeriatenela细胞培养模型上研究了评价抗球虫剂的程序,包括投药时间、效果评定指标、药物有效浓度及毒性浓度、细胞培养有效浓度及鸡体中使用浓度之相关性等内容。试验结果表明药物溶剂影响药物效能的发挥。... 本文作者在Eimeriatenela细胞培养模型上研究了评价抗球虫剂的程序,包括投药时间、效果评定指标、药物有效浓度及毒性浓度、细胞培养有效浓度及鸡体中使用浓度之相关性等内容。试验结果表明药物溶剂影响药物效能的发挥。投药于球虫培养全期比其他几种投药时间更能准确地评价各种药物的效果。药物评价的指标,除子孢子的活力及裂殖体形成数量之外,卵囊形成数量更能显示出药物的作用效果。本试验确定的药物筛选程序为,用鸡肾原代细胞培养Eimeriatenela,使药物充分溶解后与子孢子一起接入细胞,培养至试验结束。 展开更多
关键词 抗球虫药 药物筛选 球虫 体外培养
下载PDF
海洋放线菌细胞毒抗肿瘤活性物质的初筛 被引量:14
12
作者 杨智源 郑忠辉 +3 位作者 黄耀坚 李军 陈晋安 苏文金 《中国海洋药物》 CAS CSCD 1999年第2期52-55,27,共5页
本文以改进的MTT法为初筛模型,筛选海洋放线菌产生的细胞毒抗肿瘤活性物质。对434株海洋放线菌发酵液的筛选结果发现,约16%的海洋放线菌发酵液对P_(388)和KB癌细胞的ID_(50)等于或大于320,其中最高可达2... 本文以改进的MTT法为初筛模型,筛选海洋放线菌产生的细胞毒抗肿瘤活性物质。对434株海洋放线菌发酵液的筛选结果发现,约16%的海洋放线菌发酵液对P_(388)和KB癌细胞的ID_(50)等于或大于320,其中最高可达20480。这表明海洋放线菌存在着活性高的细胞在抗肿瘤活性物质,是潜在的抗癌药源。 展开更多
关键词 海洋放线菌 抗肿瘤活性物质 体外筛选
下载PDF
冬凌草甲素纳米粒制备及其体外抗肿瘤作用 被引量:10
13
作者 赵永星 华海婴 梁文权 《中国医院药学杂志》 CAS CSCD 北大核心 2008年第11期864-867,共4页
目的:制备冬凌草甲素纳米粒(ORI-Nps),考察其体外抗肿瘤作用。方法:采用界面沉淀法制备ORI-Nps,并对其形态、粒径、ξ电位、包封率、载药量、体外释药特征和抗肿瘤作用进行研究。结果:制备的ORI-Nps为类球形,粒径分布均匀,平均粒径为101... 目的:制备冬凌草甲素纳米粒(ORI-Nps),考察其体外抗肿瘤作用。方法:采用界面沉淀法制备ORI-Nps,并对其形态、粒径、ξ电位、包封率、载药量、体外释药特征和抗肿瘤作用进行研究。结果:制备的ORI-Nps为类球形,粒径分布均匀,平均粒径为101.5nm;ξ电位为-29.8mV;载药量和包封率分别为6.84%和92.25%;体外释药缓慢;对Eca-109细胞具有较强的毒性作用。结论:制备的ORI-Nps包封率和载药量高,粒径均匀,体外释药具有缓释特点,体外抗肿瘤作用强。 展开更多
关键词 冬凌草甲素 纳米粒 体外释药 细胞毒性
下载PDF
抗肿瘤药物筛选中MTT法和SRB法的比较 被引量:25
14
作者 谭卫东 金红 +4 位作者 罗弟祥 钟绍东 苏芝 彭旭东 高小平 《天然产物研究与开发》 CAS CSCD 1999年第3期17-22,共6页
在抗肿瘤药物的体外筛选中 ,MTT法和 SRB法是常用的两种方法。我们用MTT法和 SRB法分别测定 3种已知植物抗癌药对 2 2株人肿瘤细胞的抗癌活性 ,对这两种方法进行了详细的比较。通过分析两种方法测出的细胞存活率 ( T/ C)的差异分布和相... 在抗肿瘤药物的体外筛选中 ,MTT法和 SRB法是常用的两种方法。我们用MTT法和 SRB法分别测定 3种已知植物抗癌药对 2 2株人肿瘤细胞的抗癌活性 ,对这两种方法进行了详细的比较。通过分析两种方法测出的细胞存活率 ( T/ C)的差异分布和相关系数以及 IC50 的二变量分布 ,比较了两种方法测定结果的异同 ;通过两种方法重复测定 3种药物对 7株人癌细胞的抗癌活性 ,比较了两种方法的重复性 ;通过分析两种方法测定结果 T/ C值随时间变化的程度 ,比较了两种方法测定结果的稳定性。实验结果表明 :MTT法和 SRB法的相关性较好 ,都可用于抗肿瘤药物的体外筛选 ,SRB法更适合于大规模筛选 ,3种抗癌药物的测定结果与临床资料基本一致。 展开更多
关键词 MTT法 SRB法 抗肿瘤药物 体外筛选
下载PDF
PHBV/葡聚糖纳米药物载体的制备及表征 被引量:3
15
作者 刘海蓉 张清卿 +4 位作者 周征 胡薏冰 张水寒 戴瑶 李永生 《湖南大学学报(自然科学版)》 EI CAS CSCD 北大核心 2018年第6期113-119,共7页
两亲性聚合物纳米颗粒作为疏水性抗肿瘤药物载体因其能够增强化疗效率并降低毒副作用而受到广泛关注.采用双乳液溶剂挥发法制备了聚(3-羟基丁酸酯-co-3-羟基戊酸酯)(PHBV)/葡聚糖纳米颗粒,测得平均粒径为205.0±6.9nm,Zeta电势为-1.... 两亲性聚合物纳米颗粒作为疏水性抗肿瘤药物载体因其能够增强化疗效率并降低毒副作用而受到广泛关注.采用双乳液溶剂挥发法制备了聚(3-羟基丁酸酯-co-3-羟基戊酸酯)(PHBV)/葡聚糖纳米颗粒,测得平均粒径为205.0±6.9nm,Zeta电势为-1.59±0.12mV,纳米颗粒具有明显的壳核结构,粒径均一,分散性良好.将疏水性化疗药物顺铂包载后,其粒径及电势均无明显变化,载药量达19.3±2.9%.顺铂在模拟肿瘤细胞环境pH=5.5的磷酸盐缓冲液(PBS)中比正常细胞环境pH=7.4时释放更快,且累计释放周期均长达7d以上,表明该药物载体具有一定的pH响应性以及优异的缓释性能.细胞集落形成实验表明PHBV/葡聚糖纳米药物载体具有良好的生物相容性,而载药纳米颗粒对肿瘤细胞的毒性明显高于正常细胞,表明该纳米颗粒对肿瘤细胞具有更强的杀伤作用.综上所述,PHBV/葡聚糖纳米颗粒具有两亲性分子结构,合适的粒径及Zeta电势,显著的缓释效果,对肿瘤细胞具有pH响应性及更强的杀伤作用等优势,有望成为一种新型纳米药物载体,在癌症化疗中显著提高药物利用率并降低毒副作用. 展开更多
关键词 PHBV 葡聚糖 纳米颗粒 药物载体 体外药物释放 细胞毒性
下载PDF
蜂胶超临界CO_2萃取物的体外抗肿瘤试验研究 被引量:6
16
作者 高寅飞 马海乐 +1 位作者 王振斌 王文兵 《肿瘤》 CAS CSCD 北大核心 2007年第2期115-117,共3页
目的研究蜂胶的超临界CO2萃取物的体外抗肿瘤作用。方法以蜂胶的超临界CO2萃取物(SE-P)为原料,采用MTT法研究其对U937、95D、SGC-7901和TE-1共4株肿瘤细胞的体外抑制作用,并与市售蜂胶乙醇提取物(ME-P)和蜂胶超临界CO2萃余物95%乙醇提取... 目的研究蜂胶的超临界CO2萃取物的体外抗肿瘤作用。方法以蜂胶的超临界CO2萃取物(SE-P)为原料,采用MTT法研究其对U937、95D、SGC-7901和TE-1共4株肿瘤细胞的体外抑制作用,并与市售蜂胶乙醇提取物(ME-P)和蜂胶超临界CO2萃余物95%乙醇提取物(RE-P)的抗肿瘤活性进行对比。结果SE-P在体外对肿瘤细胞U937、95D、SGC-7901和TE-1具有较强的抑制作用,IC50分别为117.42μg/mL、138.92μg/mL、37.76μg/mL和67.89μg/mL。除95D细胞外,SE-P对其他3株肿瘤细胞的最高抑制率均高于ME-P和RE-P。结论蜂胶的超临界CO2萃取物(SE-P)对体外培养的肿瘤细胞有较强的生长抑制作用。 展开更多
关键词 药物筛选试验 抗肿瘤 蜂胶 体外 肿瘤细胞 培养的
下载PDF
肝脏体外模型及其在毒理学方面的应用 被引量:6
17
作者 蔡燕 宫丽崑 任进 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2004年第5期390-395,共6页
肝脏体外模型发展很快并日趋成熟。目前 ,常用的肝脏体外模型包括原代肝细胞模型、离体肝脏模型、肝脏切片模型、肝细胞系模型、亚细胞模型及基因工程细胞模型等 ,其中原代肝细胞模型最为常用。上述模型除了可以应用于药物肝脏毒性机制... 肝脏体外模型发展很快并日趋成熟。目前 ,常用的肝脏体外模型包括原代肝细胞模型、离体肝脏模型、肝脏切片模型、肝细胞系模型、亚细胞模型及基因工程细胞模型等 ,其中原代肝细胞模型最为常用。上述模型除了可以应用于药物肝脏毒性机制的研究之外 ,还可以用于药物毒性的高通量筛选。在今后的研究中 ,如何改善肝脏体外模型的培养条件及完善药物肝脏毒性研究体系是急需解决的课题。 展开更多
关键词 实验模型 肝脏 体外 毒性实验 药物筛选
下载PDF
抗癌药物对体外胃癌细胞生长的抑制作用 被引量:8
18
作者 艾军 何兰欣 +2 位作者 梁索源 任金荣 段建萍 《河北医科大学学报》 CAS 2002年第1期19-21,共3页
目的探讨 8种抗癌药物对体外胃癌细胞株的抑制作用。方法选用不同剂量的抗癌药物与胃癌细胞株BGC 82 3孵育不同时间后 ,用MTT法测定其细胞增长抑制率。结果 8种抗癌药物对细胞抑制率顺序 :顺铂(diamminedichloroplatinum ,DDP) ,足叶乙... 目的探讨 8种抗癌药物对体外胃癌细胞株的抑制作用。方法选用不同剂量的抗癌药物与胃癌细胞株BGC 82 3孵育不同时间后 ,用MTT法测定其细胞增长抑制率。结果 8种抗癌药物对细胞抑制率顺序 :顺铂(diamminedichloroplatinum ,DDP) ,足叶乙甙 (etoposide,VP 16 ) ,5 氟脲嘧啶 (5 fluorouracilum ,5 Fu) ,长春新碱(vincristin ,VCR) ,阿霉素 (adriamycin ,ADM) ,丝裂霉素 (mitomycin ,MMC) ,阿糖胞苷 (arabinosylcytosine ,Ara c) ;对氨甲喋呤 (methotrexate,MTX)不敏感。其抑制率有随药物浓度增加、作用时间延长而增高的趋势。结论 8种抗癌药物除MTX外 ,对BGC 82 3细胞均有明显的抑制作用 ,但存在一定差异 ;从本实验条件看 ,以中等浓度。 展开更多
关键词 抗癌药 体外胃癌细胞生长 抑制作用 胃肿瘤 药物筛选试验
下载PDF
细胞色素P450酶系的异源表达研究 被引量:4
19
作者 程婕 龚毅 杨凌 《河北大学学报(自然科学版)》 CAS 北大核心 2006年第3期331-336,共6页
传统的药物代谢主要以实验动物为对象进行药物早期及临床研究,近几年来,结合生物化学与分子生物学的发展,药物早期代谢研究进入到药物体外代谢的研究阶段,主要围绕人肝内参与代谢的细胞色素P450家族展开.本文就近年来对此家族酶的异源... 传统的药物代谢主要以实验动物为对象进行药物早期及临床研究,近几年来,结合生物化学与分子生物学的发展,药物早期代谢研究进入到药物体外代谢的研究阶段,主要围绕人肝内参与代谢的细胞色素P450家族展开.本文就近年来对此家族酶的异源表达及其在药物代谢中的应用进行了综述. 展开更多
关键词 药物体外代谢 细胞色素P450s(CYPs) 异源表达 药物筛选
下载PDF
紫杉醇纳米胶束冻干粉针剂的制备工艺研究 被引量:4
20
作者 杜卓 潘仕荣 +5 位作者 余巧 杨海云 许晓琳 谭银合 卢碧玉 梁伟光 《中药新药与临床药理》 CAS CSCD 北大核心 2013年第5期510-514,共5页
目的制备紫杉醇/聚乙二醇-聚谷氨酸苄酯纳米胶束的冻干粉针剂。方法以胶束粒径、有机溶剂残留量等为评价指标,采用膜透析法制备纳米胶束;以冻干成品的外观形态、体外释药曲线为评价指标,优选冻干粉针剂的制剂处方;研究粉针剂的冻干工艺... 目的制备紫杉醇/聚乙二醇-聚谷氨酸苄酯纳米胶束的冻干粉针剂。方法以胶束粒径、有机溶剂残留量等为评价指标,采用膜透析法制备纳米胶束;以冻干成品的外观形态、体外释药曲线为评价指标,优选冻干粉针剂的制剂处方;研究粉针剂的冻干工艺及该粉针剂对HepG-2肝癌细胞的体外细胞毒性。结果以3%甘露醇为比例,制备获得紫杉醇纳米胶束冻干粉针剂外观良好,其体外释药曲线具有突释与缓释特性,且与新鲜透析所得载药纳米胶束溶液的释药曲线基本相同;当紫杉醇浓度≤10μg·mL-1时,冻干粉针剂对HepG-2肝癌细胞的细胞毒性远低于市售紫杉醇注射剂(P<0.01)。结论采用膜透析结合冷冻干燥法制备紫杉醇纳米胶束冻干粉针剂,避免使用紫杉醇增溶剂(聚氧乙烯蓖麻油)带来的不良过敏反应,并降低对体外肝癌细胞的细胞毒性,具有较好的临床价值与应用前景。 展开更多
关键词 紫杉醇 聚乙二醇-聚谷氨酸苄酯 纳米胶束 冻干粉针剂 体外释药 细胞毒性
下载PDF
上一页 1 2 4 下一页 到第
使用帮助 返回顶部